MENTOR, Ohio, Nov. 10 /PRNewswire-FirstCall/ -- STERIS Corporation will hold an analyst conference on Tuesday, November 15 in Cleveland, Ohio where senior management will discuss the Company’s business and growth strategies. Formal presentations will begin at 8:00 a.m. Eastern time, with an hour and a half break for lunch beginning at noon, and will conclude at 3:30 p.m. Presenting will be Les C. Vinney, president and chief executive officer; Laurie Brlas, chief financial officer; Charles L. Immel, group president, Healthcare; Gerry Reis, group president, Life Sciences; and Robert E. Moss, group president, STERIS Isomedix Services.
The presentations can be heard live over the Internet at www.steris-ir.com. For those unable to listen to the presentations live, a replay will be available from 5:30 p.m. Eastern time on Tuesday, November 15, until 5:00 p.m. Eastern time on Tuesday, November 29 at www.steris-ir.com.
About STERIS
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. The Company’s more than 5,000 dedicated employees around the world work together to supply a broad array of solutions by offering a combination of equipment, consumables and services to healthcare, pharmaceutical, industrial and government customers. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.
This news release or the referenced presentations may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to the Company or its industry that are intended to qualify for the protections afforded “forward- looking statements” under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “targets,” “forecasts,” and “seeks,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in the forward-looking statements including, without limitation, disruption of production or supplies, changes in market conditions, political events, pending or future claims or litigation, competitive factors, technology advances, and changes in government regulations or the application or interpretation thereof. Other risk factors are described in the Company’s Form 10-K and other securities filings. Many of these important factors are outside STERIS’s control. No assurances can be provided as to any future financial results. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, (a) the potential for increased pressure on pricing or raw material cost that leads to erosion of profit margins, (b) the possibility that market demand will not develop for new technologies, products or applications, or the Company’s business initiatives will take longer, cost more or produce lower benefits than anticipated, (c) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent new product introductions, affect the production and marketing of existing products, or otherwise affect Company performance, results, or value, (d) the potential of international unrest or effects of fluctuations in foreign currencies of countries where the Company does a sizeable amount of business, (e) the possibility of reduced demand, or reductions in the rate of growth in demand, for the Company’s products and services, and (f) the possibility that the anticipated gain on the sale of the freeze dryer product line may not be realized.
STERIS Corporation
CONTACT: Julie Winter, Manager, Investor Relations of STERIS Corporation,+1-440-392-7245
